Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

MDA to develop advanced technology solutions for paediatric surgery

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/20/2012 | 11:57pm CEST


For immediate release: February 20, 2012

MDA to develop advanced technology solutions for paediatric surgery

Richmond, B.C. - MacDonald, Dettwiler and Associates Ltd. (TSX: MDA), a provider of essential information solutions, announced today that it has signed a Master Research Collaboration Agreement with the Children's National Medical Center (Children's National) in Washington, D.C. Through this collaborative partnership, MDA and Children's National will develop advanced medical robotics and "smart tools" to improve the quality of patient outcomes for children's surgeries. The initial phase is valued at US$2.7 million.

'The Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National builds partnerships, such as this one with MDA, that will truly shift the paradigm of pediatric surgery,' said Peter Kim, Vice President of the Sheikh Zayed Institute and Associate Surgeon in Chief at Children's National. 'The tools and robotics we conceive together moving forward will represent the first generation technology specifically to focus on precision in children's surgery.'

'We're extremely excited to expand our medical business to provide surgeons with the most advanced tools available,' said Craig Thornton, the general manager responsible for this business area. 'We are continually assessing complex surgical procedures that can be performed more effectively and safely utilizing our innovative robotic solutions.'

About MDA

MDA provides advanced information solutions that capture and process vast amounts of data, produce essential information, and improve the decision making and operational performance of business and government organizations worldwide.

Focused on markets and customers with strong repeat business potential, MDA delivers a broad spectrum of information solutions, ranging from complex operational systems, to tailored information services, to electronic information products.

The Company's common shares trade on the Toronto Stock Exchange under the symbol TSX:MDA.

Related Websites:
www.mdacorporation.com
www.ChildrensNational.org/SheikhZayedSurgicalInstitute

Forward-Looking Statements
This release contains forward-looking statements and information, which reflect the current view of MacDonald, Dettwiler and Associates Ltd. ("MDA") with respect to future events and financial performance. The forward-looking statements in this regard include statements regarding the award of a contract. Any such forward-looking statements are based on MDA's current expectations, estimates, projections and assumptions in light of its experience and its perception of historical trends. The factors and assumptions underlying the forward-looking statements in this release include contracts not being terminated. Any such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from current expectations. MDA cautions readers that should certain risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary significantly from those expected. The risks that could cause actual results to differ from current expectations include failure of third parties and subcontractors; failure of systems to meet performance requirements and failure to anticipate changes in technology, technical standards and product offerings or comply with the requisite standards.

For additional information with respect to certain of these risks or factors, plus additional risks or factors, reference should be made to the Company's continuous disclosure materials filed from time to time with Canadian securities regulatory authorities, which are available online at www.sedar.com or on the Company's website at www.mdacorporation.com.

The Toronto Stock Exchange has neither approved nor disapproved the form or content of this release.


For more information, please contact:

Wendy Keyzer
MDA External Relations
Telephone: 604-231-2743
E-mail: [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
07:00p CastleLine Delivers Certified Loan Program to help Maximize Returns and Minimize Repurchase Risk; Altisource Portfolio Solutions S.A.Plaza Home Mortgage provides Peoples Mortgage protection from loan manufacturing defects and fraud by leveraging the CastleLine Certified Loan Program
07:00p XAP CORPORATION : Awarded Contract for College and Career Planning System for the Department of Defense Education Activity
06:58p VANC PHARMACEUTICALS : Marijuana company Aphria met with TSX about guidance regarding U.S. business
06:58pDJLUXOTTICA : 3Q Sales Fall; Backs Guidance for 2017
06:58p KERING : Statement in compliance with article 223-16 of the General Regulation of the French Financial Markets Authority (October 2017)
06:54p ADP : Comments on Glass Lewis Recommendation
06:54p BH GLOBAL : Transaction in Own Shares
06:53p LUZ SAÚDE : HBA ERAS Program Distinguished with Healthcare Excellence Award
06:53p SVB FINANCIAL : Sherpa Foundry and Silicon Valley Bank Join Forces to Create Silicon Foundry
06:53p TEVA PHARMACEUTICAL INDUSTRIES : Glancy Prongay & Murray Reminds Investors of the October 23rd Deadline in the Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. (TEVA)
Latest news "Companies"
Advertisement